- Home
- LB vs CNMD Comparison
LB vs CNMD Comparison
Compare LB & CNMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LB
- CNMD
- Stock Information
- Founded
- LB 1992
- CNMD 1970
- Country
- LB United States
- CNMD United States
- Employees
- LB N/A
- CNMD N/A
- Industry
- LB
- CNMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- LB
- CNMD Health Care
- Exchange
- LB NYSE
- CNMD Nasdaq
- Market Cap
- LB 1.5B
- CNMD 1.7B
- IPO Year
- LB 2024
- CNMD 1987
- Fundamental
- Price
- LB $69.87
- CNMD $49.75
- Analyst Decision
- LB Buy
- CNMD Buy
- Analyst Count
- LB 8
- CNMD 5
- Target Price
- LB $56.75
- CNMD $77.20
- AVG Volume (30 Days)
- LB 618.0K
- CNMD 530.8K
- Earning Date
- LB 05-07-2025
- CNMD 04-30-2025
- Dividend Yield
- LB 0.29%
- CNMD 1.59%
- EPS Growth
- LB N/A
- CNMD 108.33
- EPS
- LB 0.07
- CNMD 4.25
- Revenue
- LB $109,954,000.00
- CNMD $1,307,015,000.00
- Revenue This Year
- LB $78.36
- CNMD $5.97
- Revenue Next Year
- LB $16.81
- CNMD $5.63
- P/E Ratio
- LB $969.63
- CNMD $11.85
- Revenue Growth
- LB 50.90
- CNMD 5.00
- 52 Week Low
- LB $18.75
- CNMD $46.00
- 52 Week High
- LB $84.70
- CNMD $78.58
- Technical
- Relative Strength Index (RSI)
- LB N/A
- CNMD 37.75
- Support Level
- LB N/A
- CNMD $46.00
- Resistance Level
- LB N/A
- CNMD $57.17
- Average True Range (ATR)
- LB 0.00
- CNMD 3.18
- MACD
- LB 0.00
- CNMD -0.41
- Stochastic Oscillator
- LB 0.00
- CNMD 27.40
About LB LANDBRIDGE COMPANY LLC
LandBridge Co LLC is engaged in managing land and resources to support and promote oil and natural gas development. It generates revenue streams from the use of its surface acreage, the sale of resources from land and oil and gas royalties.
About CNMD CONMED Corporation
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.